# Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload

> **NCT00673608** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 118 (actual)

## Conditions studied

- Hemoglobinopathies
- Myelodysplastic Syndromes
- Other Inherited or Acquired Anaemia
- MPD Syndrome
- Diamond-Blackfan Anemia
- Other Rare Anaemias
- Transfusional Iron Overload

## Interventions

- **DRUG:** deferasirox

## Key facts

- **NCT ID:** NCT00673608
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00673608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00673608, "Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00673608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*